These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 7300762)

  • 41. Chronic heart failure in the elderly: vasodilator therapy.
    Satinsky JD
    Angiology; 1983 Aug; 34(8):509-16. PubMed ID: 6412599
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Variable acute effects of prazosin on left ventricular failure (author's transl)].
    Hepp A; Schick KD; Larbig D; Haasis R; Liebau G; Riegger G; Kochsiek K
    Dtsch Med Wochenschr; 1980 Nov; 105(47):1647-50. PubMed ID: 7439046
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of prazosin on forearm resistance and capacitance vessels.
    Awan NA; Miller RR; Maxwell K; Mason DT
    Clin Pharmacol Ther; 1977 Jul; 22(1):79-84. PubMed ID: 872499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical pharmacology and therapeutic application of prazosin in acute and chronic refractory congestive heart failure. Balanced systemic venous and arterial dilation improving pulmonary congestion and cardiac output.
    Awan NA; Miller RR; Miller MP; Specht K; Vera Z; Mason DT
    Am J Med; 1978 Jul; 65(1):146-54. PubMed ID: 685987
    [No Abstract]   [Full Text] [Related]  

  • 45. The effects of prazosin in severe congestive heart failure. An echocardiographic study.
    Drăgulescu SI; Comşulea L; Streian C
    Med Interne; 1984; 22(1):29-33. PubMed ID: 6710045
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nonparenteral vasodilator therapy for chronic congestive heart failure.
    Chatterjee K; Brundage BH; Ports TA
    Compr Ther; 1979 Nov; 5(11):48-55. PubMed ID: 116798
    [No Abstract]   [Full Text] [Related]  

  • 47. [Immediate and long-term effects of prazosin on hemodynamics in chronic cardiac insufficiency].
    Champoud O; Brunhes G; Cribier A; Pasquis P; Letac B
    Arch Mal Coeur Vaiss; 1982 Jun; 75(6):687-93. PubMed ID: 6810798
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of ibopamine plus prazosin in congestive heart failure.
    Naidoo DP; Rocke A; Mitha AS
    S Afr Med J; 1998 Feb; 88 Suppl 1():C25-31. PubMed ID: 9542492
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Vasodilator therapy of pump failure in acute myocardial infarction].
    Trongé J; Villamayor RM; Pérez Baliño N; Riccitelli MA; Bertolasi CA; Bertolasi CA
    Cardiology; 1980; 66 Suppl 2():154-61. PubMed ID: 7285026
    [No Abstract]   [Full Text] [Related]  

  • 50. Renal perfusion changes during treatment of essential hypertension: prazosin versus propranolol.
    O'Connor DT; Preston RA; Sasso EH
    J Cardiovasc Pharmacol; 1979; 1(6 Suppl):S38-42. PubMed ID: 94638
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications.
    Colucci WS
    Ann Intern Med; 1982 Jul; 97(1):67-77. PubMed ID: 6124197
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Guidelines for vasodilator therapy of congestive heart failure in infants and children.
    Artman M; Graham TP
    Am Heart J; 1987 Apr; 113(4):994-1005. PubMed ID: 3031972
    [No Abstract]   [Full Text] [Related]  

  • 53. The acute and chronic haemodynamic effects of prazosin in severe congestive cardiac failure.
    Harper RW; Claxton H; Middlebrook K; Anderson S; Pitt A
    Med J Aust; 1980 Jul; 2(SP1):36-8. PubMed ID: 7421721
    [No Abstract]   [Full Text] [Related]  

  • 54. Acute and chronic cardiocirculatory effects of oral prazosin in chronic refractory heart failure.
    Hayashi H; Sassa H; Oba M; Fukaya T; Okubo M; Niwa T; Matsui E
    Jpn Heart J; 1980 Nov; 21(6):827-36. PubMed ID: 7007686
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Changes in renal arterial flow during the treatment of essential arterial hypertension; prazosin in comparison with propranolol].
    O'Connor DT; Preston RA; Sasso EH
    Cardiology; 1980; 66 Suppl 2():69-73. PubMed ID: 7285032
    [No Abstract]   [Full Text] [Related]  

  • 56. [Improved kidney function with intravenous prostaglandin E1 in patients with terminal heart failure].
    Wutte M; Hülsmann M; Berger R; Rödler S; Frey B; Stanek B; Pacher R
    Wien Klin Wochenschr; 1998 Jul; 110(13-14):473-8. PubMed ID: 9746960
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prazosin and hydralazine in congestive heart failure. Regional hemodynamic effects in relation to dose.
    Magorien RD; Triffon DW; Desch CE; Bay WH; Unverferth DV; Leier CV
    Ann Intern Med; 1981 Jul; 95(1):5-13. PubMed ID: 7247126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Vasodilator therapy of congestive heart failure: comparison of hemodynamic effects after administration of nitroprusside i.v. and oral prazosin (author's transl)].
    Mauri F; Gronda E; Bossi M; Rovelli F
    G Ital Cardiol; 1980; 10(4):414-23. PubMed ID: 7439582
    [No Abstract]   [Full Text] [Related]  

  • 59. Effect of vasodilator drugs on exercise performance in cardiac failure. Comparison of hydralazine and prazosin.
    Fitchett DH; Pathé M; Pardy R; Despas P
    Br Heart J; 1980 Aug; 44(2):215-20. PubMed ID: 7426176
    [No Abstract]   [Full Text] [Related]  

  • 60. [Prazosin in arterial hypertension with cardiac insufficiency].
    Antani JA
    Cardiology; 1980; 66 Suppl 2():132-7. PubMed ID: 6456812
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.